What we’re about
mHealth Israel is a non profit organization comprised of entrepreneurs, investors, developers and healthcare professionals applying IT, mobile and healthcare expertise toward connected health innovation. Our goal is to transform Israel into the world connected health technology leader. Monthly events, international Roadshows, a free online database and the annual mHealth Israel conference (the largest digital health conference in Israel) helps unite the Israeli healthcare community with elite global partners, investors, acquirers and thought-leaders. Please also join our LinkedIn community: https://www.linkedin.com/groups/6929224
Upcoming events (3)
See all- July 23rd WEBINAR: Japan WOMEN in HealthTech VCLink visible for attendees
Japan is the world #3 market (by revenue) for both medical devices and pharma. For each of the last five years, venture investment in Japan has outpaced growth in Europe and North America. On July 23rd, don't miss a truly unique opportunity to hear directly from four leading Japan HealthTech WOMEN in VC: Yukiko Kato, SBI Investments; Yumiko Murakami, mPower Partners; Nagisa Sakurai, Astellas Venture Management; Felicia Chung, Olympus. Moderated by Fern Lazar, FINN Partners.
Title: Japan HealthTech WOMEN in VC
Date: July 23rd
Time: 9am ET / 4pm IL
URL: https://finnpartners.zoom.us/j/99635053469?pwd=CKuXfObzLfAJaxpZyRxnxxy7hU4mlQ.pnvqhzjC8aWeQZWq
Passcode: 675187
Agenda: 10 minute overview, 35 minute panel, 10 minute Q&A
Speakers: Yukiko Kato, SBI Investments; Yumiko Murakami, mPower Partners; Nagisa Sakurai, Astellas Venture Management; Felicia Chung, Olympus. Moderated by Fern Lazar, FINN PartnersThese are four of the most prominent HealthTech VC investors, collectively responsible for billions in Assets Under Management, spanning major corporates like Astellas, Olympus, Softbank and their dozens of prominent strategic corporate Limited Partners. See you at the webinar on July 23rd, 9am ET: "Japan HealthTech Women in VC".
- The Exit BLUEPRINT: M&A for Tech FoundersHerzog law, Tel Aviv
M&A for Tech Founders is a complex, high stakes process. Two people who have accompanied dozens of tech Founders through this process over several decades will share their perspectives, Sunday, August 10th, 9:15am at Herzog Towers in Tel Aviv.
Title: The EXIT Blueprint- M&A for Tech Founders
Date: Sunday, August 10th
Time: 9:15-11:15am
Venue: Herzog Towers, 6 Sadeh Street, Tel Aviv
Speakers: Adam Salkin, M&A Partner, Herzog; Goel Jasper, Manager Partner- Israel office, FINN Partners
Agenda:
Goel Jasper- IR and Communications across stakeholders
Adam Salkin- Best Practices for before, during and after transactionA valuable resource for tech companies at any stage. Join "The Exit Blueprint- M&A for Tech Founders" Sunday, August 10th, 9:15am at Herzog Towers in Tel Aviv.
- Reimbursement Bootcamp with David FarberHerzog law, Tel Aviv
Postponed until December due to hostilities with Iran.
Reimbursement is a laborious, expensive process, requiring the same amount of resources (human, financial and time) as FDA. Yet, too often, this crucial step is overlooked. On Sunday, June 15th, 9-11am, David Farber, Head of Reimbursement at King & Spalding LLC, will lead a 90 minute Reimbursement Bootcamp, followed by your Q&A. As a reference, please see David's previous Bootcamp lecture HERE
Title: Reimbursement Bootcamp for MedTech and Digital Health
Date: Rescheduled to December.
Time: 9-11am
Lecture: Link HERE
Agenda: Introductory remarks from Goel Jasper, followed by lecture from David Farber.
Venue: Herzog law firm, Yitzhak Sadeh St 6, Tel Aviv-Yafo, 6777506, IsraelEssential insights for medtech / digital health / biotech companies that actually want to MAKE MONEY in the US.
